Cargando…

Challenges and Pitfalls of Using Repeat Spirometry Recordings in Routine Primary Care Data to Measure FEV(1) Decline in a COPD Population

BACKGROUND: Electronic healthcare records (EHR) are increasingly used in epidemiological studies but are often viewed as lacking quality compared to randomised control trials and prospective cohorts. Studies of patients with chronic obstructive pulmonary disease (COPD) often use the rate of forced e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whittaker, Hannah R, Kiddle, Steven J, Quint, Jennifer K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420778/ https://www.ncbi.nlm.nih.gov/pubmed/34512071 http://dx.doi.org/10.2147/POR.S319965

Ejemplares similares

Accelerated FEV(1) decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients
por: Whittaker, Hannah R., et al.
Publicado: (2021)

Inhaled corticosteroids, blood eosinophils, and FEV(1) decline in patients with COPD in a large UK primary health care setting
por: Whittaker, Hannah R, et al.
Publicado: (2019)

Inhaled corticosteroids and FEV(1) decline in chronic obstructive pulmonary disease: a systematic review
por: Whittaker, Hannah R., et al.
Publicado: (2019)

Prediction of five-year mortality after COPD diagnosis using primary care records
por: Kiddle, Steven J., et al.
Publicado: (2020)

Routine spirometry in cystic fibrosis patients: impact on pulmonary exacerbation diagnosis and FEV(1) decline
por: de Aquino, Carolina Silva Barboza, et al.
Publicado: (2022)

Changes in FEV(1) over time in COPD and the importance of spirometry reference ranges: the devil is in the detail
por: Kirkby, Jane, et al.
Publicado: (2019)

Characteristics Associated with Accelerated Lung Function Decline in a Primary Care Population with Chronic Obstructive Pulmonary Disease
por: Whittaker, Hannah R, et al.
Publicado: (2020)

Risk factors for FEV(1) decline in mild COPD and high-risk populations
por: Chen, Shujing, et al.
Publicado: (2017)

Adverse health consequences in COPD patients with rapid decline in FEV(1 )- evidence from the UPLIFT trial
por: Kesten, Steven, et al.
Publicado: (2011)

Exploring the impact of varying definitions of exacerbations of chronic obstructive pulmonary disease in routinely collected electronic medical records
por: Whittaker, Hannah, et al.
Publicado: (2023)

Lower FEV(1) in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV(1), total IgE levels, and TSLP genotypes
por: Masuko, Hironori, et al.
Publicado: (2011)

Cut-off value of FEV(1)/FEV(6) to determine airflow limitation using handheld spirometry in subjects with risk of chronic obstructive pulmonary disease
por: Hwang, Yong Il, et al.
Publicado: (2021)

Bronchodilator response cut-off points and FEV (0.75) reference values for spirometry in preschoolers
por: Burity, Edjane Figueiredo, et al.
Publicado: (2016)

Annual decline rate in FEV1s in community-dwelling older adults diagnosed with mild to moderate COPD
por: Rosso, Aldana, et al.
Publicado: (2022)

A blood and bronchoalveolar lavage protein signature of rapid FEV(1) decline in smoking-associated COPD
por: DiLillo, Katarina M., et al.
Publicado: (2023)

Identifying COPD in routinely collected electronic health records: a systematic scoping review
por: Sivakumaran, Shanya, et al.
Publicado: (2021)

Use of spirometry and recording of smoking habits of COPD patients increased in primary health care during national COPD programme
por: Vasankari, Tuula, et al.
Publicado: (2011)

Rate of Decline of FEV(1) as a Biomarker of Survival?
por: Papi, Alberto, et al.
Publicado: (2021)

Diagnosis, assessment, and phenotyping of COPD: beyond FEV(1)
por: Lange, Peter, et al.
Publicado: (2016)

Machine learning for screening of at-risk, mild and moderate COPD patients at risk of FEV(1) decline: results from COPDGene and SPIROMICS
por: Wang, Jennifer M., et al.
Publicado: (2023)

COPD assessment test and FEV(1): do they predict oxygen uptake in COPD?
por: Carvalho-Jr, Luiz Carlos S, et al.
Publicado: (2018)

COPD-associated miR-145-5p is downregulated in early-decline FEV(1) trajectories in childhood asthma
por: Tiwari, Anshul, et al.
Publicado: (2020)

“Mild” COPD: What Spirometry Conceals!
por: O’Donnell, Denis E.
Publicado: (2017)

Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study
por: Whittaker, Hannah, et al.
Publicado: (2022)

Predictive Value of Combining Inflammatory Biomarkers and Rapid Decline of FEV(1) for COPD in Chinese Population: A Prospective Cohort Study
por: Wang, Yunxia, et al.
Publicado: (2019)

Obstructive sleep apnoea accelerates FEV(1) decline in asthmatic patients
por: Wang, Tsai-Yu, et al.
Publicado: (2017)

Inflammatory and immunological profiles in patients with COPD: relationship with FEV (1) reversibility
por: Queiroz, Cleriston Farias, et al.
Publicado: (2016)

Low FEV1 Is Associated With Increased Risk Of Cachexia In COPD Patients
por: Mokari-Yamchi, Amin, et al.
Publicado: (2019)

Pulmonary function testing in COPD: looking beyond the curtain of FEV1
por: Kakavas, Sotirios, et al.
Publicado: (2021)

FVC, but not FEV(1,) is associated with clinical outcomes of asthma-COPD overlap
por: An, Tai Joon, et al.
Publicado: (2022)

Feasibility of spirometry in primary care to screen for COPD: a pilot study
por: Giraud, Violaine, et al.
Publicado: (2016)

Fixed Cut-Off for FEV1/FEV6 and FEV6 in Detection of Obstructive and Restrictive Patterns
por: Aghili, Rokhsareh, et al.
Publicado: (2013)

Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare Records
por: Rothnie, Kieran J., et al.
Publicado: (2016)

Systematic review of the evidence relating FEV(1 )decline to giving up smoking
por: Lee, Peter N, et al.
Publicado: (2010)

Spirometry Longitudinal Data Analysis Software (SPIROLA) for Analysis of Spirometry Data in Workplace Prevention or COPD Treatment
por: Hnizdo, Eva, et al.
Publicado: (2010)

Beyond FEV(1) in COPD: a review of patient-reported outcomes and their measurement
por: Jones, Paul, et al.
Publicado: (2012)

Validity and interpretation of spirometric recordings to diagnose COPD in UK primary care
por: Rothnie, Kieran J, et al.
Publicado: (2017)

COPD diagnosis related to different guidelines and spirometry techniques
por: Nathell, Lennart, et al.
Publicado: (2007)

Absence of airflow obstruction on spirometry: can it still be COPD?
por: Neder, José Alberto, et al.
Publicado: (2020)

Validation of the recording of idiopathic pulmonary fibrosis in routinely collected electronic healthcare records in England
por: Morgan, Ann, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_66lne50hd09mt91ipvrk4hpnt9